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Objective: Restoring the circulation is the primary goal in emergency treatment of cerebral ischemia. However, bet-
ter understanding of how the brain responds to energy depletion could help predict the time available for resuscita-
tion until irreversible damage and advance development of interventions that prolong this span. Experimentally,
injury to central neurons begins only with anoxic depolarization. This potentially reversible, spreading wave typically
starts 2 to 5 minutes after the onset of severe ischemia, marking the onset of a toxic intraneuronal change that even-
tually results in irreversible injury.
Methods: To investigate this in the human brain, we performed recordings with either subdural electrode strips
(n54) or intraparenchymal electrode arrays (n55) in patients with devastating brain injury that resulted in activation
of a Do Not Resuscitate–Comfort Care order followed by terminal extubation.
Results: Withdrawal of life-sustaining therapies produced a decline in brain tissue partial pressure of oxygen (ptiO2)
and circulatory arrest. Silencing of spontaneous electrical activity developed simultaneously across regional electrode
arrays in 8 patients. This silencing, termed “nonspreading depression,” developed during the steep falling phase of
ptiO2 (intraparenchymal sensor, n5 6) at 11 (interquartile range [IQR]57–14) mmHg. Terminal spreading depolariza-
tions started to propagate between electrodes 3.9 (IQR5 2.6–6.3) minutes after onset of the final drop in perfusion
and 13 to 266 seconds after nonspreading depression. In 1 patient, terminal spreading depolarization induced the
initial electrocerebral silence in a spreading depression pattern; circulatory arrest developed thereafter.
Interpretation: These results provide fundamental insight into the neurobiology of dying and have important implica-
tions for survivable cerebral ischemic insults.
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The brain is the most vulnerable organ of the body tohypoxia and ischemia. Neocortical pyramids of layers
III, IV, and V, hippocampal CA1 pyramidal cells, striatal
cells, and cerebellar Purkinje cells display the highest vulner-
ability.1,2 Massive, irreversible injury of these cells develops
within <10 minutes when circulation completely ceases,
such as after cardiac arrest.3,4 The pathophysiological cas-
cades resulting in this injury have been extensively investi-
gated in various animal species for more than half a
century. However, in humans, scalp electroencephalographic
(EEG) recordings have only conveyed a vague hint at what
truly happens in the brain when the circulation ceases.5
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Accordingly, interpretations and conclusions vary widely in
the clinical literature, including views deviating significantly
from the observations in animals. For example, notions are
at times encountered that brain death occurs when the
EEG becomes silent. Other notions recognize that neurons
of the human cortex can remain polarized for several
minutes during electrical silence associated with acute, com-
plete ischemia, and that failure of membrane pumps there-
after would indicate the tissue’s death.6 However, animal
studies demonstrate that such failure only initiates the cyto-
toxic processes leading to death and only occurs as a conse-
quence of a terminal depolarization wave, a phenomenon
that has not yet been documented in the human brain.
In animals, complete global ischemia causes com-
plete electrical inactivity (ie, isoelectricity) of affected
gray matter within about 20 to 40 seconds.7 This cere-
bral silencing is regarded as an austerity program to curb
neuronal energy usage by the shutdown of nonessential
cell functions well before the neuronal adenosine triphos-
phate (ATP) pool is depleted and prospects of tissue
recovery vanish.4,8 Accordingly, the electrical inactivity
corresponds to a hyperpolarization of neurons,9 which
may be mediated by several mechanisms, as reviewed
recently.10 A hallmark of electrical silencing after onset of
severe ischemia is its simultaneous development in
affected tissue, which has been termed “nonspreading
depression.”11 Despite this austerity program, sodium
and calcium always leak into cells and potassium leaks
out. These movements are driven by the release of Gibbs
free energy. Eventually, ATP is depleted and the Na,K-
ATPase fails to restore the leaking ions. When a thresh-
old level of failure, usually reached 1 to 5 minutes after
nonspreading depression, has rendered the ischemic tissue
isoelectric, neurons then undergo abrupt, nonlinear run-
down in the ion gradients across the cellular membranes.
This depolarization develops en masse from either one or
multiple foci and spreads in the tissue as a self-
propagating wave.7,9,12–14 Initially termed “anoxic” or
“asphyxial” depolarization,15 this spreading depolarization
(SD) initiates a plethora of toxic changes, including
intracellular calcium and sodium loading, steep rise in
extracellular glutamate, and cytotoxic edema, as reviewed
recently.16–18 Importantly, cellular injury does not
develop during the initial period of nonspreading depres-
sion, but only begins with a delay after SD ignition.10
Knowledge of analogous pathologic processes in
the human brain would inform not only research on
treatment strategies of cardiac arrest and stroke that
may complement efforts to reestablish circulation, but
also the debate on organ donation after cardiocircula-
tory death (DCD), where death is declared between 2
and 10 minutes following the cessation of circulatory
function.19–21 Therefore, here we analyzed the sequence
of pathophysiologic events in patients during abrupt
hypoxia–ischemia after withdrawal of life-sustaining
treatments. Patients underwent neuromonitoring with
intracranial electrodes during intensive care treatment
following aneurysmal subarachnoid hemorrhage (aSAH)
and clip ligation of the aneurysm, decompressive hemi-
craniectomy for malignant hemispheric stroke (MHS),
or traumatic brain injury (TBI). Following poor clinical
course and family discussion, neuromonitoring was con-
tinued through the dying process after activation of a
Do Not Resuscitate–Comfort Care (DNR-CC) order.
Materials and Methods
Patients undergoing invasive neuromonitoring were enrolled at
Charite–Universit€atsmedizin Berlin (n5 4) and the University
of Cincinnati Medical Center (n5 5) in research protocols
approved by the local ethics committees; written informed con-
sent was obtained from the patients’ legally authorized represen-
tatives. Research was conducted in accordance with the
Declaration of Helsinki.
In 3 patients with aSAH, a linear electrode strip (6 plat-
inum/iridium [Pt/Ir] contacts spaced at 10mm; Wyler, Ad-
Tech Medical Instrument Corporation, Oak Creek, WI) was
placed on the cortical surface of the vascular territory of the
aneurysm-carrying vessel following surgery to secure the aneu-
rysm (Fig 1B).22,23 In 1 patient with MHS, the electrode strip
was placed on perfused, noninfarcted peri-infarct tissue after
decompressive hemicraniectomy.24,25 In 5 patients with TBI,
an intraparenchymal depth electrode array (8 Pt/Ir contacts
spaced at 2.2mm; Spencer, Ad-Tech Medical) was placed in
the frontal lobe through a multilumen bolt after admission to
neurocritical care.26 In Patient 5 of Tables 1 and 2, the elec-
trode array was implanted on the left side with no lesions pre-
sent, contralateral to subdural hematoma (Fig 2A). By
contrast, the array was located in the right hemisphere in 3
other patients with extensive bifrontal hemorrhagic contusions
and another one with perforating gunshot wound from right
temporoparietal through left occipital regions. Subdermal plat-
inum needles placed at the ipsilateral mastoid were used as
reference.
Continuous electrocorticography (ECoG) and multi-
modal monitoring were performed following the recently pub-
lished recommendations of the Co-Operative Studies on Brain
Injury Depolarizations (COSBID) while patients were in neuro-
critical care.16 For aSAH patients and the MHS patient, elec-
trodes were connected to a BrainAmp amplifier (BrainProducts,
Munich, Germany) and data were acquired with BrainVision
Recorder software (BrainProducts). For TBI patients, recordings
were made with the Component Neuromonitoring System
(Moberg ICU Solutions, Ambler, PA). In both groups, ampli-
fiers were direct current (DC)-coupled (0–100Hz). In 2
patients, a subdural optoelectrode strip allowed the simulta-
neous measurement of ECoG and regional cerebral blood flow
(rCBF) using laser-Doppler flowmetry (LDF; Perimed, J€arf€alla,
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Sweden).22,27,28 In 2 other patients, rCBF was monitored with
a parenchymal thermal diffusion probe (Hemedex, Cambridge,
MA).29 Tissue partial pressure of oxygen (ptiO2) was measured
using an intraparenchymal sensor in 6 patients (Licox CC1P1;
Integra Lifesciences Corporation, Plainsboro, NJ).22,29–31 Intra-
cranial pressure (ICP) was monitored via ventricular drainage
FIGURE 1.
Dreier et al: Terminal SD
February 2018 297
catheter (extraventricular drainage [EVD]) or ICP transducer
(Codman, San Jose, CA or Camino Laboratories, San Diego,
CA). The systemic arterial pressure was continuously recorded
via radial artery catheter.
Data Analysis
All data in text and figures are given as median, 1st quartile,
and 3rd quartile. No patients were excluded from the analysis.
The data were analyzed in an unblinded fashion with
LabChart-7 software (ADInstruments, Bella Vista, Australia).
The first 24-hour period after the initial insult was
denoted as “day 0.” SDs were identified by the consecutive
occurrence of slow potential changes (<0.05Hz) of neighboring
ECoG channels. In electrically active tissue, SD typically causes
spreading depression of spontaneous activity in the alternating
current (AC)-ECoG range (0.5–45Hz).23 The duration of the
depression period was scored beginning at the initial decrease
in the integral of power and ending at the start of the recovery
phase. Depression durations were scored to measure the total
depression duration per recording day (TDDD), following the
recently published recommendations of COSBID.16 The peak
TDDD (PTDDD) was defined as the maximal value among all
recording days. SDs in electrically active tissue received the epi-
thet “spreading depression.” By contrast, SDs measured in a
zone of electrically inactive tissue were denoted with the adjec-
tive “isoelectric.”16
Results
Tables 1 and 2 summarize the characteristics of 9 patients
in whom multimodal monitoring was performed after
devastating aSAH, MHS, or TBI and through the dying
process after withdrawal of life-sustaining therapies.
Illustrative Cases
PATIENT 1. Patient 1 was a 52-year-old woman with
aSAH. Until day 3, she had 13 SDs (2 spreading depres-
sions and 11 isoelectric SDs) with a PTDDD of 487.9
minutes that occurred on day 3. On the same day, a
computed tomography (CT) scan showed multiple
infarcts in the territories of the right middle cerebral
artery (MCA) and both posterior cerebral arteries. On
the following day, a control scan revealed increasing
lesions, 10mm midline shift, and beginning brain hernia-
tion. From the beginning, she required intravenous nor-
adrenaline at a rate of 0.08 mg/kg/min to maintain
adequate cerebral perfusion pressure (CPP) under seda-
tion with propofol. Stress cardiomyopathy was ruled out
using echocardiography, electrocardiography, and cardiac
biomarkers. However, noradrenaline had to be further
increased to 0.26 mg/kg/min on day 4 when she devel-
oped Staphylococcus aureus–caused pneumonia and mida-
zolam was added to the sedative regimen to control
progressive increase in ICP. Thiopental was added for the
same reason 12 hours before she died on day 6. Thio-
pental resulted in cerebral isoelectricity, and intravenous
noradrenaline had to be increased to a rate of 0.43mg/
kg/min. Eventually, a DNR-CC order was activated after
FIGURE 1: Terminal spreading depolarization (SD) during death in the human brain in comparison to terminal SD during death in the rat
brain. (A) In Patient 1, the first direct current (DC) change after terminal extubation was a very slow, homogeneous DC positivity (not
shown; cf Table 1) that began before the circulatory arrest. Terminal SD then started at electrode 4 (transition from dark blue to red DC
traces) after the arterial pressure had reached its minimum (brown trace). Systemic arterial pressure was recorded in the radial artery.
The 2 insets show the arterial pressure fluctuations during the initial period and during the arrest of the systemic circulation. Note that
there is still evidence of cardiac cycles in the right inset, but the cardiac output is too low tomaintain a sufficient systemic pressure (elec-
tromechanical dissociation). This increasingly pulseless electrical activity of the heart disappeared 30 seconds thereafter. Spontaneous
brain activity had ceased in response to the barbiturate thiopental several hours before the circulatory arrest. Therefore, no nonspread-
ing depression of activity occurred (not shown). (B) Projection of the electrodes of a typical subdural, collinear recording strip on a human
brain. (C) Dying process after circulatory arrest in a rat. (D) Original cranial window experiment using 2 subdural Pt/Ir plate electrodes for
use in humans (DC/AC-ECoG) and a laser-Doppler flowmetry (LDF) probe (regional cerebral blood flow [rCBF]). Note the steep falls in
arterial pressure and rCBF that mark the moment of circulatory arrest. In animals, the typical sequence of nonspreading depression fol-
lowed by terminal SD during global cerebral anoxia–ischemia has been extensively documented since its first description in 1947.7,11–14
Note the similarity between the patterns of the terminal SD in the rodent experiment and in the patient (red arrows in A and C). In both
cases, the terminal SD propagated fromone electrode to the next correspondingwith previous evidence from experiments in animals in
vivo and in brain slices.7,12–14 In contrast to the spread of the terminal SD, the nonspreading depression (cf asterisks) is seen in the rodent
recordings as a silencing of the spontaneous electrical activity (alternating current [AC]–electrocorticography [ECoG]: 0.5–45Hz) that
develops simultaneously across the array of the regional 2 electrodes (cf Figs 3B, 4B, 5A, 5C, and 6 for nonspreading depression in
patients). In the clinic, it has become conventional to review the raw signal alongside a leaky integral of the total power of the bandpass-
filtered (AC-ECoG) data andmeasure depression duration based on the latter.16,23 Therefore, the integral of power is shown here to dis-
play the pattern of nonspreading depression when this type of data presentation is chosen (light blue traces, cf Patient 3 in Fig 4A and
Patient 7 in Fig 6). The experimentwasperformed in amaleWistar rat (300g, 12weeks old, supplied byCharles River, Sulzfeld,Germany)
anesthetized with 100mg/kg body weight thiopental–sodium intraperitoneally (Trapanal; BYK Pharmaceuticals, Konstanz, Germany),
tracheotomized, and artificially ventilated (Effenberger Rodent Respirator; Effenberger Med.-Techn. Ger€atebau, Pfaffing/Attel, Ger-
many; approved by the Office for Occupational Safety and Health and Technical Security Berlin [G0152/11]). Sudden circulatory arrest
was induced in the rat by injection of 10ml of air into the heart via the femoral vein. This explains why mean arterial pressure rapidly
dropped in the rat in contrast to the patient, in whom the circulatory arrest developed gradually after extubation. The Supplementary
Table provides the statistical description of 5 rats with a previously healthy brain in which death resulted from sudden circulatory arrest
after air injection into the femoral vein and heart under thiopental anesthesia. aSAH5 aneurysmal subarachnoid hemorrhage.
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TABLE 1. Summary of Demographic, Treatment, and SD-Related Data of the Patients






















1 52; F Infarcts: R hem,
L O; midline shift:
10mm; brain
herniation
3 3 ACoA Aneurysm
clipping, EVD




2 56; F ICH R T; infarcts:
R hem, L Fr, L O;
midline shift: 17mm
5 3 MCA Aneurysm
clipping, EVD





3 78; F ICH: L Fr, R Fr 4 3 ACoA Aneurysm
coiling and
clipping, EVD
































































1T1 (3T) None L Fr cortex Severe
blunt TBI
3 0 22.3
6 71; M tSAH; SDH;
contusions: L Fr,
R Fr; skull
fractures: L Fr, L T
Pedestrian struck
by vehicle
3T5 (9T) None R Fr cortex Severe
blunt TBI
2 0 40.8
7 57; M tSAH; DAI; contusions:
L Fr, R Fr, L T, R T
Fall down stairs 2T5 (8T) None R Fr cortex Severe
blunt TBI
5 5 27.3

















R Fr cortex Severe
blunt TBI
5 8 115.0
ACA5 anterior cerebral artery; ACoA5ACoA5 anterior communicating artery; aSAH5 aneurysmal subarachnoid hemorrhage; DAI5diffuse
axonal injury; EDH5 epidural hematoma; EVD5 extraventricular drainage; F5 female; Fr5 frontal; GCS5Glasgow Coma Scale; hem5 hemi-
sphere; ICH5 intracerebral hemorrhage; L5 left; M5male; MCA5middle cerebral artery; MHS5malignant hemispheric stroke; O5 occipital;
PICA5posterior inferior cerebellar artery; R5 right; SD5 spreading depolarization; SDH5 subdural hematoma; T5 temporal; TBI5 traumatic
brain injury; tSAH5 traumatic subarachnoid hemorrhage; WFNS5World Federation of Neurosurgical Societies.











Initial DC Component of

















1 7.5 (7.0 to 8.2) Barbiturate-
induced
depression
— 22.8 22.6 (22.3 to 22.7) 154 (122 to 176) 42 27.3 (26.2 to 28.9)
2 20.8 (20.4 to 21.7) Nonspreading
depression
53 24.4 21.4 (21.3 to 22.9) 82 (60 to 100) 324 219.2 (215.5 to 224.0)
3 6.6 (6.3 to 8.2) Spreading and
nonspreading
depression
— 27.6 25.4 (24.1 to 26.2) 65 (64 to 113) 383 28.3 (26.7 to 29.6)
4 2.8 (2.7 to 3.2) Nonspreading
depression
13 24.6 23.7 (23.4 to 24.0) 322 (318 to 326) 10 21.9 (20.1 to 24.9)
5 2.5 (1.3 to 2.8) Nonspreading
depression
73 26.3 23.2 (21.7 to 23.7) 183 (153 to 225) 80 218.9 (216.5 to 221.6)
6 9.2 (6.7 to 10.1) Nonspreading
depression
266 20.5 20.3 (20.2 to 20.4) 97 (84 to 102) — 220.1 (214.4 to 221.3)
7 28.0 (25.6 to 29.0) Nonspreading
depression
106 20.7 20.3 (20.2 to 20.5) 94 (66 to 113) 15 22.2 (1.0 to 24.3)
8 0 Nonspreading
depression
78 20.6 20.6 (20.5 to 20.6) 398 (360 to 416) 5 25.8 (25.4 to 26.0)




IQR5 interquartile range; DC5 direct current; NUP5negative ultraslow potential; SD5 spreading depolarization; TOAD5 time of SD arrival
difference between neighboring electrodes.
FIGURE 2: Similar to the terminal spreading depolarization (SD) in subdural recordings, the terminal SD in recordings with
depth electrodes shows an initial and a late negative direct current (DC) component. (A) The computed tomogram of Patient 5
displays the intraparenchymal electrode array in the left frontal hemisphere with no lesions present. (B) The late component,
the so-called negative ultraslow potential (NUP), is similar to the negative DC shifts of prolonged SD, but specifically refers to
a negative potential component generated by progressive recruitment of neurons into cell death in the wake of SDs (terminal
SD at electrode 3 of Patient 5).16 AC5 alternating current; ECoG5electrocorticography.
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family discussion and the patient was terminally extu-
bated. Withdrawal of the life-sustaining treatment
resulted in complete circulatory arrest after 17 minutes.
Figure 1A shows the time course of the systemic arterial
pressure including the circulatory arrest and subsequent
terminal SD that started at electrode 4 and then spread
to the other electrodes. For comparison, Figure 1C dis-
plays a typical terminal SD of a rodent brain after injec-
tion of air into the heart via the femoral vein
(experimental setup in Fig 1D); circulatory arrest is fol-
lowed by nonspreading depression and then terminal
SD. The Supplementary Table provides the statistical
data of 5 thiopental-anesthetized rats with previously
healthy brains in which death resulted from sudden cir-
culatory arrest by air injection into the femoral vein.
PATIENT 2. Patient 2 was a 56-year-old woman with
aSAH. ICP increased up to 25mmHg despite EVD, arti-
ficial ventilation, and analgosedation. She became hemo-
dynamically unstable and required intravenous
noradrenaline at a rate of 0.56 mg/kg/min. ECoG and
LDF displayed 5 SDs, which induced spreading depres-
sions of activity, spreading ischemias of up to 190-second
duration (Fig 3A), and spreading suppressions of low-
frequency vascular fluctuations.22 Spreading ischemia
concurred with disturbed autoregulation similar to a pre-
vious report.29 Accordingly, ptiO2 seemed to follow the
fluctuations of mean arterial pressure (MAP). The
PTDDD was 102.3 minutes and occurred on day 1.
In addition to a large intracerebral hemorrhage
(ICH) in the right temporal lobe, magnetic resonance
imaging (MRI) on day 1 revealed large infarcts in the
territories of both anterior cerebral arteries, the right
MCA, and both posterior cerebral arteries, as well as
lacunar infarcts in right thalamus and pons. On day 2, a
family discussion was held and a DNR-CC order was
activated. The patient was terminally extubated. Figure
3B shows the nonspreading depression of activity during
the falling phase of ptiO2. A very slow, homogeneous
DC positivity started simultaneously with the drop in
ptiO2. Superimposed on this DC positivity, the terminal
SD then started at electrode 3.
PATIENT 3. Patient 3, a 78-year-old woman, showed
large bifrontal ICH in addition to aSAH. She had 12
SDs on days 2 and 3, and 1 on day 10. One SD was a
spreading convulsion.32 The others were classified as
spreading depressions. The PTDDD was 144.1 minutes
and occurred on day 2. Her past medical history was sig-
nificant for liver cirrhosis of unknown etiology. During
her clinical course, she developed a hepatorenal syndrome
with progressive failure of liver, kidneys, lungs, and circu-
lation. A family discussion was held and a DNR-CC
order was activated followed by terminal extubation on
day 11. As shown in Figure 4A, the ECoG showed a
deviation from the 2 previous cases because the terminal
SD started in electrode 3 at 7 minutes before the circula-
tory arrest. In this moment, spontaneous brain activity
was still present. Accordingly, the terminal SD induced
spreading depression at electrode 3. From electrode 3,
the SD spread to the other electrodes. Finally, nonspread-
ing depression rendered the remaining spontaneous brain
activity isoelectric while the terminal SD was still propa-
gating. Presumably, the last SD originated from the rim
of the previous ICH. The circulatory arrest then con-
verted this SD into a terminal one.
PATIENT 4. Patient 4, a 63-year-old man with previous
myocardial infarction, hypertension, and diabetes melli-
tus, suffered from a CT-proven infarct of the complete
right MCA territory. Decompressive hemicraniectomy
was performed 37 hours after onset of the left-sided
hemiparesis. On day 4, MRI additionally revealed
infarcts in the vascular territories of the left MCA and
right posterior inferior cerebellar artery as well as both
cerebellar hemispheres. No SDs were recorded before the
terminal one. A family discussion was held and a DNR-
CC order was activated followed by terminal extubation
on day 5. Figure 4B shows the nonspreading depression
of activity during the falling phase of ptiO2. A very slow,
homogeneous DC positivity started simultaneously with
the drop in ptiO2. Superimposed on this DC positivity,
the terminal SD then started at electrode 3.
PATIENT 5. Patient 5 was a 47-year-old male occupant
of a car struck by a train with reported field Glasgow
Coma Scale (GCS)5 3. The patient was intubated for
airway protection and arrived at the trauma center with
presentation GCS5 3T. Bilateral chest tubes were placed
for traumatic pneumothoraces. Once stabilized, the
patient had a postresuscitation GCS5 1T3. CT of the
head demonstrated skull vault fractures, diffuse traumatic
SAH, subdural hematoma, and diffuse petechial shear
injuries. He was admitted to neurocritical care, and an
ICP monitor was placed with elevated ICP noted. A
family discussion was held on day 2, a DNR-CC order
was activated, and the patient was terminally extubated.
Similar to Patients 2 and 4, nonspreading depression
occurred while ptiO2 showed the final drop. The termi-
nal SD started 73 seconds after nonspreading depression
had rendered the ECoG isoelectric (Fig 5A, B).
PATIENT 6. Patient 6 was a 71-year-old male pedes-
trian struck by a vehicle with reported field GCS5 14.
The patient was intubated for airway compromise, and
arrived at the trauma center with presentation
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GCS5 3T5. His primary survey revealed polytrauma
with gross limb deformities and signs of craniofacial
injury. A Focused Assessment with Sonography for
Trauma examination was negative; CT of the head
revealed diffuse traumatic SAH and a small falcine sub-
dural hematoma. He was found to have coagulopathy by
admission laboratory evaluation. After resuscitation and
correction of coagulopathy, the patient was admitted to
neurocritical care and an ICP monitor was placed.
Repeat cranial imaging demonstrated worsening bifrontal
contusions and an enlarging left temporal contusion. The
patient’s neurologic examination declined to GCS5 3T
despite aggressive medical management for refractory
ICP. A family discussion was held on day 2, at which
time a DNR-CC order was activated. The patient was
terminally extubated. The end-of-life recordings are
shown in Figure 5C.
PATIENT 7. Patient 7 was a 57-year-old male who was
found at the base of a stairway. The patient neurologically
deteriorated in the field, with decline in the GCS from 13
to 8, was intubated in the emergency department, and
was admitted to the neuroscience intensive care unit. CT
scans showed hemorrhagic contusions, subdural hema-
toma, and traumatic SAH. ICP, ptiO2, and rCBF probes,
and intraparenchymal depth electrodes were placed in the
right frontal lobe and continuous scalp DC/AC-EEG was
monitored using Ag/AgCl-electrodes. Five SDs were
FIGURE 3: Comparison of spreading depolarization (SD)-induced spreading depression versus nonspreading depression fol-
lowed by terminal SD in death. (A) In Patient 2, electrocorticography (ECoG) and laser-Doppler flowmetry displayed 5 SDs,
which induced spreading ischemias (SIs) of up to 190-second duration, spreading depressions of activity, and spreading sup-
pressions of low-frequency vascular fluctuations.22 Spreading ischemia concurred with disturbed autoregulation. Accordingly,
tissue partial pressure of oxygen (ptiO2) seemed to follow the fluctuations of mean arterial pressure (MAP; cf asterisks). Oxy-
gen is known to interfere with platinum. Accordingly, the fluctuations of ptiO2 are reflected in the direct current (DC) record-
ings (cf dark blue asterisks). (B) Discontinuation of the life-sustaining measures caused progressive decline in MAP, regional
cerebral blood flow (rCBF), and ptiO2. Nonspreading depression (cf X’s) rendered the brain isoelectric within 338 seconds after
onset of the decline in MAP or, respectively, 220 seconds after rCBF had fallen to 20% of baseline. A very slow, homogeneous
DC positivity (cf Table 2) started simultaneously with the drop in ptiO2 (cf asterisks). Superimposed on this DC positivity, the
terminal SD started in electrode 3, 53 seconds after complete cessation of spontaneous activity (transition from dark blue to
red DC traces). From electrode 3, terminal SD spread to the other electrodes. Note that the terminal SD shows an initial and a
late negative DC component (cf Fig 2B and Table 2). AC5 alternating current.
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observed on day 2, and elevated ICP at >40mmHg
became intractable despite administration of muscle relax-
ants, pentobarbital, and 3% saline. Per discussions with
family, a DNR-CC order was placed on day 5 and the
patient was terminally extubated. Approximately 10
minutes thereafter, a slow, homogeneous DC shift was
observed on intraparenchymal DC/AC-ECoG and scalp
DC/AC-EEG electrodes in synchrony with the decline in
oxygen saturation and PtiO2, a final ICP spike, and declin-
ing cerebral perfusion and respiratory arrest. Nonspreading
depression was observed across intraparenchymal and scalp
electrodes during the falling phase of ptiO2. Asystole for
20 seconds began 3 minutes later, only 13 seconds before
the start of terminal SD (Fig 6).
Nonspreading Depression and Terminal SD in
Human Intracranial Recordings following
Circulatory Arrest
In general, terminal events were initiated with circulatory
arrest after withdrawal of life-sustaining treatment. The
FIGURE 4: Electrocerebral silence in death can develop in a spreading or nonspreading pattern. (A) In Patient 3, the first direct
current (DC) change after discontinuation of the life-sustaining measures was again a very slow, homogeneous DC positivity (cf
Table 2). However, electrocorticography (ECoG) showed a deviation from the 2 previous cases, because terminal spreading
depolarization (SD; transition from dark blue to red DC traces) started in electrode 3 at 7 minutes before the circulatory arrest.
In this moment, spontaneous brain activity was still present. Accordingly, the terminal SD induced spreading depression at
electrode 3 (cf light blue asterisks). From electrode 3, SD spread to the other electrodes. During the SD-induced spreading
depression, a pulse artifact, similar to previous observations,32 developed at electrode 4. Finally, nonspreading depression ren-
dered the remaining spontaneous brain activity isoelectric while the terminal SD was still propagating. (B) Patient 4 suffered
from malignant hemispheric stroke. Discontinuation of life-sustaining measures caused progressive decline in mean arterial
pressure, regional cerebral blood flow, and tissue partial pressure of oxygen (ptiO2) followed by nonspreading depression (cf
X’s) and terminal SD. First DC change was a very slow, homogeneous DC positivity. Similar to Patient 2, it started together
with the decline in ptiO2. Note the fall in brain temperature after the circulatory arrest. (C) Patient 4’s longest time of terminal
SD arrival difference between 2 neighboring electrodes is displayed. AC5 alternating current.
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time period from withdrawal of life-sustaining treatment
to complete circulatory arrest was 23 (interquartile range
[IQR]5 19–30) minutes (range5 16–101 minutes). In
Case 9, the recordings ended with the circulatory arrest,
whereas they continued for another 33 (IQR5 21–40)
minutes in the remaining 8 patients. Following circulatory
arrest, brain temperature dropped at a rate of 0.044
(IQR5 0.032–0.052) 8C/min (n5 4; see Figs 4B, 6).
Circulatory arrest caused a simultaneous nonspread-
ing depression of activity across the electrode array in
8 of 9 patients. In 3 patients, scalp EEG recordings con-
firmed that nonspreading depression occurred simulta-
neously not only at intracranial electrodes, but also
throughout the hemisphere (see Fig 6). At the time of
nonspreading depression onset, brain ptiO2 values were
11 (IQR5 7–14) mmHg (n5 6), MAP was 25
(IQR5 23–37) mmHg (n5 5), CPP was 22
(IQR5 19–28) mmHg (n5 5), ICP was 11 (IQR5 6–
25) mmHg (n5 7), and rCBF was 16% (IQR5 6–
29%) compared to baseline (100%; n5 4). Respiration
simultaneously ceased with the nonspreading depression
in 3 of 3 cases (see Figs (5 and 6)). Nonspreading
depression was followed by negative DC shifts of termi-
nal SD after delays ranging 13 to 266 seconds (see Table
2; Figs 3B, 4–6). Patient 8 was an outlier, because an
ICP increase to 100mmHg in parallel with a decline in
ptiO2 to 6mmHg caused nonspreading depression at a
CPP of 25mmHg followed by terminal SD >3 hours
before extubation and arrest of the systemic circulation.
In the 1 case not showing nonspreading depression, elec-
trocerebral silence was induced prior to death by barbitu-
rate medication (Patient 1). However, the patient
FIGURE 5: Nonspreading depression followed by terminal spreading depolarization (SD) recorded with intraparenchymal elec-
trode arrays. (A) In Patient 5, similar to Patients 2 and 4, nonspreading depression occurred while tissue partial pressure of
oxygen (ptiO2) showed the final drop (cf asterisks). When the electrocorticography (ECoG) became isoelectric, mean arterial
pressure had fallen to 18mmHg and ptiO2 to 0.6mmHg. The first direct current (DC) change was a very slow, homogeneous DC
positivity. Similar to Patient 2 and 4, it started together with the decline in ptiO2. The terminal SD started superimposed on
the homogeneous DC positivity 73 seconds after nonspreading depression had rendered the ECoG isoelectric. (B) shows an
overlay of electrodes 3, 4, and 6 from recordings in A, illustrating the time of SD arrival difference of the terminal SD. (C) The
end-of-life recordings in Patient 6 showed nonspreading depression (cf asterisks) similar to A. Also, the diffuse changes of the
DC potential are similar to A. Although the part of the curve where the terminal SD starts may be derived from the compari-
son with A, occurrence of the terminal SD is more speculative in C, because amplitudes are smaller and spread between elec-
trodes was less obvious. AC5 alternating current.
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displayed a terminal SD in the wake of the circulatory
arrest (see Fig 1). Patient 9 showed nonspreading depres-
sion, but recordings ended before the terminal SD.
After onset of the final drops in perfusion (marked
by asterisks in Figure 3B), terminal SDs abruptly started
with a delay of 3.9 (IQR5 2.6–6.3) minutes. When ter-
minal SD reached the last electrode, brain ptiO2 values
were 2 (IQR5 1–6) mmHg (n5 5), MAP was 15
(IQR5 13–37) mmHg (n5 7), CPP was 13 (IQR5 8–
21) mmHg (n5 7), ICP was 9 (IQR5 1–10) mmHg
(n5 7), rCBF was 3% (IQR5 2–21%; n5 3), and res-
piration had ceased (n5 3). Increasingly pulseless electri-
cal activity of the heart could continue for 5.1
(IQR5 0.3–10.6) minutes beyond the onset of terminal
FIGURE 6: Scalp electroencephalographic (EEG) recordings indicated that nonspreading depression occurs simultaneously not
only at intracranial electrodes, but also throughout the hemisphere. In Patient 7, approximately 10 minutes after terminal extu-
bation, a slow, homogeneous direct current (DC) shift was observed on intraparenchymal DC/alternating current (AC)–electro-
corticography (ECoG) and scalp DC/AC-EEG electrodes in synchrony with the decline in oxygen saturation (not shown) and
tissue partial pressure of oxygen (ptiO2), a final intracranial pressure spike, and declining cerebral perfusion. Nonspreading
depression (cf light blue asterisks) was then observed across intraparenchymal and scalp electrodes during the fall of ptiO2.
Asystole for 20 seconds began 3 minutes later (not shown), only 13 seconds before the start of terminal SD. Note the correlate
of the terminal spreading depolarization (SD) in the scalp DC/AC-EEG. Brain temperature was recorded in this case. Note the
transient rise in brain temperature during terminal SD followed by decline thereafter.
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SD (n5 6). As explained above, the sequence of events
was more complex in Patient 3, because terminal SD
started before the final drop in perfusion. The circulatory
arrest then developed as the SD spread. As a result, the
terminal pattern of electrical silencing was a mixture of
spreading and nonspreading depression (see Fig 4A).
DC shifts of terminal SD were usually superim-
posed on a very slow DC drift that occurred simulta-
neously on all electrodes. These slow drifts are likely
caused by multiple sensitivities of Pt/Ir electrodes and/or
generated at the blood–brain barrier (BBB; cf discussion),
as they coincided with changes in cerebral variables such
as ptiO2 (see Figs 3B, 4B, 5, 6). Simultaneous slow DC
drifts were also observed at all electrodes in 3 patients
with scalp EEG recordings (see Fig 6).
In animals, the SD extreme in ischemic tissue is
characterized by prolonged depolarization durations, in
addition to a slow baseline variation termed the negative
ultraslow potential (NUP). The NUP is initiated by SDs
and similar to the negative DC shifts of prolonged SD,
but specifically refers to a negative potential component
generated by progressive recruitment of neurons into cell
death in the wake of SDs.16 These two potential compo-
nents of the terminal SD are illustrated, for example, in
Figure 2B (depth electrode) and Figure 3B (subdural
electrode). The amplitude of the initial component of
the terminal SD, representing the actual SD process, was
22.0 (IQR521.5 to 22.8) mV (n5 8). The ampli-
tude of the subsequent NUP was 27.8 (IQR526.4,
29.3) mV. It should, however, be noted that the record-
ings usually ended before the NUP had reached its full
negativity (see Fig 2B).
In all 4 subdural electrode strip recordings, the
spreading nature of the terminal DC shift was evidenced
by differences in the time of SD arrival among the elec-
trodes (see Table 2, Figs 1A, 3B, 4A, 4C). With depth
electrodes, the spread of DC shifts was evidenced in 2 of
4 cases (see Figs 5A, 5B, 6). In 2 other cases, unequivocal
delay between different electrodes was not seen (see
Fig 5C).
Discussion
In patients with acute brain injury, subdural ECoG has
shown that persistent states of electrical silence in cortex
are in many cases induced by SD, because the initial
depression occurs in a spreading pattern.22–24,33,34 There-
after, SDs can repetitively invade the already silent tissue
but cannot induce further depression, and are thus
termed “isoelectric” SDs.16,35,36 However, it was
unknown whether a new, abruptly developing hypoxic–
ischemic insult in the human brain causes electrocortical
silence in the pattern of nonspreading depression, as in
animals. It was further unknown whether such a pattern
is followed by the depolarization, known as anoxic or ter-
minal SD.15 In patients with malignant hemispheric
stroke after MCA occlusion, electrophysiological moni-
toring begins hours after the initial insult,24,25 precluding
observation of nonspreading depression and anoxic SD
in the ischemic core region near the time of ischemic
onset. However, a different situation exists in the case of
moribund patients when a medical decision is reached to
withdraw life-sustaining therapies, because intracranial
electrodes are already in place when circulatory arrest
acutely induces severe hypoxia–ischemia. Thus, here we
performed continuous patient monitoring following
DNR-CC orders to investigate mechanisms of acute cere-
bral ischemia and the relative timing of circulatory and
cerebral events in the dying process.
Nonspreading Depression of Activity
We found electrophysiological evidence for the occur-
rence of nonspreading depression in 8 patients undergo-
ing global cerebral ischemia. Subdural electrode strips
covered the cortical surface at 6 adjacent locations over a
distance of 5cm, whereas intraparenchymal depth arrays
were recorded from a single location but extended
through cortex as well as white matter. Combining these
two approaches, it was possible to demonstrate that the
depression of activity following global arrest of the circu-
lation does not spread in either the horizontal or the ver-
tical plane. Thus, the term nonspreading depression
accurately describes this phenomenon. Nonspreading
depression typically preceded the terminal SD by several
tens of seconds, similar to previous observations in ani-
mals.7 It has been proposed that the underlying mecha-
nism of nonspreading depression is related to a neuronal
or glial oxygen sensor that shuts down neuronal activity
once it senses a steep decline in ptiO2.
4 Accordingly, we
found here in patients with simultaneous recordings of
ECoG and ptiO2 that nonspreading depression occurred
during a steep decline in ptiO2.
In the case of focal ischemia, the initial SD devel-
oping in the electrically silent hypoxic–ischemic zone also
propagates through ischemic border zones into normally
perfused and spontaneously active tissue against the gra-
dients of oxygen, glucose, and perfusion. Notably, this
wave and all SD waves, whether in well-nourished or
severely ischemic tissue, maintain their essential defining
features such as the spreading nature, degree of ionic
changes, and cytotoxic edema, among others.10,17 None-
theless, several characteristics and consequences of SD
change depending on local tissue conditions, including
duration/persistence of depolarization, cellular toxicity,
hemodynamic response, and pharmacology. These
ANNALS of Neurology
306 Volume 83, No. 2
variations are described as the SD continuum.10,17 A crit-
ical aspect of the continuum is that SD induces a spread-
ing depression of spontaneous electrical activity in tissue
that is healthy or only mildly ischemic, as complete neu-
ronal depolarization precludes the generation of action
potentials and postsynaptic potentials. Thus, whether
electrical silence of cortical tissue develops in a non-
spreading or spreading pattern distinguishes whether the
changes are induced by a newly developing insult of
severe hypoxia–ischemia, or by SD as a secondary pro-
cess, respectively.
Terminal SD
The human recordings with subdural electrode strips did
not suggest gross differences with animal recordings con-
cerning nature, timing, or propagation of the terminal
SD, but a fraction of the time of SD arrival differences
between neighboring electrodes was relatively short. This
could reflect a multifocal origin, as others have noted
that if conditions for SD are very favorable, it may spon-
taneously originate from several foci practically simulta-
neously, so that spread is only evident with detailed
spatiotemporal mapping provided by neuroimaging
techniques.13,15
In 1 of the patients, terminal SD started before
arrest of the systemic circulation. Possibly, this SD origi-
nated at the rim of a CT-proven ICH. The electrophysi-
ological pattern during the dying process is interesting in
this patient, because it is analogous to experiments in
rabbits by Aristides Le~ao in which he interrupted the cir-
culation after first triggering an SD that propagated
through the tissue with accompanying spreading depres-
sion. As a consequence of the circulatory arrest, the nega-
tive DC shift became prolonged.7 Our observation here
suggests that this constellation can also occur in humans
and further strengthens Le~ao’s notion that “in the spread-
ing depression, a change of the same nature as one,
resulting from prolonged interruption of the circulation,
occurs in the cerebral cortex. The electrical sign of this
change is the negative slow voltage variation.”7
Failure of the energy-dependent recovery under
continued oxygen and glucose depletion is the most obvi-
ous discriminator between SD in ischemic and normal
tissue.37 Accordingly, the negative DC shift of SD
becomes one of indefinite duration under anoxia–severe
ischemia. However, anoxia-triggered SD is fully reversible
without any signs of cellular damage, if the oxidative
substrate supply is reestablished before the so-called com-
mitment point, defined as the time when neurons start
dying under persistent depolarization.3,4,38 The delay
between SD onset and the commitment point, which can
range from a few minutes to >10 minutes, depends
critically on the absolute local level of perfusion and tem-
perature, and differs between different types of neu-
rons.2,39,40 Terminal SD, as used presently, describes the
particular cases of SD when it is confirmed that the com-
mitment point is reached and/or that repolarization never
occurs, as in death. Importantly, the reversibility of per-
sistent depolarization and the concept of the commit-
ment point indicate that the onset of the brain’s terminal
SD does not mark the onset of brain death, but only of
the toxic changes eventually leading to death.
Limitations
In patients, the current gold standard for the recording
of DC potentials is subdural Pt/Ir plate electrode strips
on the brain surface.16 Pt/Ir-based intraparenchymal
depth arrays can also be used for clinical monitoring.41
The advantage of intraparenchymal depth arrays, in con-
trast to subdural electrode strips, is that they can be
placed at the bedside in the intensive care unit. However,
a disadvantage is that the positioning of electrode con-
tacts of an intraparenchymal array relative to cortex in
gyri and sulci is less certain. For instance, the long SD
arrival differences for Patient 5 may reflect an electrode
array location along and in close proximity to a sulcal
cortex band, where the DC potential is generated. How-
ever, often only 1 or 2 contacts are located in gyral cor-
tex, with the others in deeper white matter where SD
does not occur. The unfavorable geometry may explain
why intraparenchymal depth arrays unequivocally dis-
played the propagation of the terminal SD in only 2 of
4 patients. In addition, the tissue in proximity to the
electrode array had no lesions present in Patient 5, and
in animals, terminal SD is the more pronounced the
more the tissue is intact until the dying process begins
because more cells can be recruited into the
depolarization.
Both subdural and intraparenchymal Pt/Ir electro-
des show a good safety profile in humans,27,42 but it
should be noted that electrode polarization of platinum
causes significant distortion and underestimation of the
true amplitude of the negative DC shift.43,44 Moreover,
platinum displays a strong catalytic capacity for many
chemical reactions in biological media. Thus, recordings
from intracranial platinum electrodes reflect not only the
DC potential of SD, but likely also the signals of ptiO2
and pH.22,30,45,46 Such contamination may explain the
large, homogeneous DC potential deflections in both
gray and white matter in the end-of-life recordings.
These overlapped with the terminal SD. They seemed to
start with the final drop in ptiO2, which in addition is
characterized by progressive acidification.46,47 This tim-
ing suggests that they resulted, at least partially, from
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interferences of ptiO2 and pH with platinum. However, a
complementary hypothesis posits that the homogeneous
DC potential deflections were in part of biological rather
than solely of artificial origin, because the DC potential
generated at the BBB is strongly influenced by tissue par-
tial pressure of CO2 (ptiCO2) and O2.
48–50 PtiO2
decreases whereas ptiCO2 increases after terminal extuba-
tion, and the appearance of the DC potential deflections
would accord with a DC potential generated at the BBB,
because they were typically characterized by a homoge-
neous laminar profile throughout cortex and white mat-
ter, in contrast to the zonal gradients observed during
functional activation, electrographic seizure activity, or
SD.50 In addition, appearance of the homogenous DC
potential deflections in the scalp recordings supported
their generation at the BBB.49,50 Although ptiCO2
recordings were not performed here, they would be inter-
esting to study in relation to ICP and SD, especially con-
sidering that SDs are known to abolish cerebrovascular
reactivity to ptiCO2, which should blunt ptiCO2’s effect
on ICP.51
TBI patients with intraparenchymal Pt/Ir electrodes
and aSAH patients with subdural electrodes showed typi-
cal differences such as a preponderance of women in
aSAH and of men in TBI, and a higher proportion of
patients with SDs after aSAH than after TBI.18 Addi-
tionally, the lower number of captured SDs in the TBI
patients was presumably due to restricted sampling of
intraparenchymal arrays.52 No information was available
regarding whether the patients suffered from migraine
aura during their lifetime. Migraine with aura could pre-
dispose to an earlier onset of terminal SD.53 However,
fundamental differences of terminal SD between patients
with and without migraine with aura during their life-
time or between patients with and without previous
brain injuries are unlikely, because all properly investi-
gated animal species with a somewhat more complex cen-
tral nervous system, including mammals, reptiles, and
insects, display terminal SD during the dying
process.15,54,55
Conclusion
In this observational study, we found that nonspreading
depression and terminal SD occur in patients in the
acutely injured brain undergoing global cerebral ischemia
in the dying process. These results confirm that the
human brain responds to acute severe cerebral ischemia
by the same sequence of pathological processes as origi-
nally described by Aristides Le~ao in animals with previ-
ously healthy brains.7 In slight deviation from the
condition of systemic circulatory arrest reported here,
Le~ao had discovered this in a model of global cerebral
ischemia in which he produced sudden ischemia of the
rabbit cortex by clamping temporarily the common
carotid arteries with the basilar artery occluded at the
level of the pons, and the external carotid arteries tied
just above their origin. Knowledge of these pathologic
mechanisms informs treatment strategies that comple-
ment the reestablishment of the systemic circulation, as
neuroprotective interventions could be directed at the
depolarization wave with the aim of prolonging the sur-
vival time. Potential treatment approaches targeting SDs
have been discussed elsewhere.10,11,56–58
Because the mere absence of spontaneous EEG
activity is ambiguous concerning the onset of cytotoxic
cellular processes leading to cortical death, a noninva-
sive clinical method to diagnose the onset of terminal
SD, as well as its reversal upon return of the circula-
tion, may have practical value for recovery prognosis
and as an indication/endpoint for resuscitation efforts.
It has been shown that the negative DC shifts of SD
can be detected with scalp DC-EEG,33,59 although
important ambiguities remain and further research is
needed to develop a reliable technique. In the case of
abrupt ischemia, recordings might be particularly com-
plicated by large BBB-generated DC potentials due to
ptiO2 and ptiCO2 changes.
49,50 Nonetheless, results
presented here should have immediate relevance to the
biological understanding of human brain death,60
which should at least require the occurrence of termi-
nal SD in cerebral gray matter. Our results suggest that
this occurs with a certain biological variability after cir-
culatory arrest and cessation of spontaneous brain
activity, which may have implications for ethical
debates concerning DCD. There is presently no indica-
tor—experimental or clinical—to determine when ter-
minal SD becomes irreversible (ie, when restoration of
function is no longer possible), yet the depolarized
state after circulatory arrest will not reverse spontane-
ously in the absence of intervention.
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